C-R. Xu

Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial.

Yi-long Wu, W. Feng, W. Zhong, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A dendritic cell‐based tumour vaccine for lung cancer: full‐length XAGE‐1b protein‐pulsed dendritic cells induce specific cytotoxic T lymphocytes in vitro

Y. Wu, S. An, Q. Zhou, 2008, Clinical and experimental immunology.

Biomarker-integrated study of single agent targeting molecular alterations of PI3KCA, MET, ALK, ROS1, KRAS, NRAS or BRAF in advanced NSCLC: Phase 2 umbrella trial in China (CTONG1505).

Y. Wu, H-J. Chen, A. Myers, 2018, Annals of Oncology.

Epidermal growth factor receptor double activating mutations involving both exons 19 and 21 exist in Chinese non-small cell lung cancer patients.

Rachel Liao, J. Yang, Y. Wu, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).